Enhabit, Inc. (NYSE:EHAB) Receives Consensus Recommendation of “Reduce” from Brokerages

Shares of Enhabit, Inc. (NYSE:EHAB) have been assigned a consensus recommendation of “Reduce” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating and six have issued a hold rating on the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $9.25.

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. AREX Capital Management LP boosted its stake in shares of Enhabit by 2.5% during the 2nd quarter. AREX Capital Management LP now owns 2,472,662 shares of the company’s stock worth $22,056,000 after purchasing an additional 59,353 shares during the period. Systematic Financial Management LP boosted its position in shares of Enhabit by 12.2% during the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after buying an additional 199,235 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of Enhabit by 1.5% during the second quarter. Dimensional Fund Advisors LP now owns 1,756,745 shares of the company’s stock valued at $15,669,000 after buying an additional 26,753 shares during the last quarter. Paradice Investment Management LLC raised its holdings in shares of Enhabit by 0.7% in the second quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock worth $13,603,000 after buying an additional 11,128 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of Enhabit by 0.9% during the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company’s stock worth $8,987,000 after acquiring an additional 10,538 shares during the last quarter.

Enhabit Price Performance

EHAB stock opened at $7.56 on Tuesday. The company has a market capitalization of $380.12 million, a PE ratio of -3.26 and a beta of 1.84. The company’s fifty day moving average price is $7.50 and its 200-day moving average price is $8.40. Enhabit has a one year low of $6.85 and a one year high of $11.74. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.

Enhabit (NYSE:EHAB) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. During the same period last year, the company earned $0.03 EPS. On average, equities analysts anticipate that Enhabit will post 0.22 EPS for the current fiscal year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.